Baqal Omar, Shafqat Areez, Kulthamrongsri Narathorn, Sanghavi Neysa, Iyengar Shruti K, Vemulapalli Hema S, El Masry Hicham Z
Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
J Clin Med. 2024 Aug 25;13(17):5031. doi: 10.3390/jcm13175031.
Despite advances in ablative therapies, outcomes remain less favorable for persistent atrial fibrillation often due to presence of non-pulmonary vein triggers and abnormal atrial substrates. This review highlights advances in ablation technologies and notable scientific literature on clinical outcomes associated with pursuing adjunctive ablation targets and substrate modification during persistent atrial fibrillation ablation, while also highlighting notable future directions.
尽管消融治疗取得了进展,但对于持续性心房颤动,由于存在非肺静脉触发灶和异常心房基质,治疗结果往往不尽人意。本综述重点介绍了消融技术的进展以及关于在持续性心房颤动消融过程中追求辅助消融靶点和基质改良相关临床结果的重要科学文献,同时也突出了显著的未来方向。